Clinical Trial Update: Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCV [NA]

View source ↗

Summary

The clinical trial evaluating Hansenula-derived pegylated interferon alpha-2a in Egyptian children with chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Hansenula-Derived Pegylated Interferon Alpha-2a (pegylated interferon alpha-2a)

Snippet

Sponsor: National Liver Institute, Egypt | Conditions: Hepatitis C, Chronic | NA | Status: COMPLETED